Baker McKenzie FenXun routinely leverages its enviable global footprint for major cross-border investment and divestment transactions. The practice has notable sector experience in healthcare, life sciences, TMT, digital infrastructure, consumer, retail and real estate. In Shanghai, China private equity head Hong Zhang is experienced in advising Chinese companies and multinationals on both China inbound and outbound investments. Over in Hong Kong, Derek Poon advises private equity firms, investment banks and major corporations on a range of corporate matters.
Testimonials
Collated independently by Legal 500 research team.
‘Very reliable team and works to tight timetables with very impressive responsiveness, attention to detail and commercial acumen.’
‘Xinxing Chen - her exceptional skills, energy and patience to manage complex, multi-party and lengthy negotiation processes and balance the demands of each party, create tremendous value for all parties involved.’
Key clients
- AGIC
- APG
- Bain Capital
- CBC Group
- CDPQ
- CMC Capital
- CPP
- Davidson Kempner
- DigitalBridge
- EQT Private Equity
- Gaw Capital
- Global Infrastructure Partners
- M3 Capital Partners
- New Frontier
- Nexus Point
- Taiko Labs
- Vitruvian Partners
- BGO
- Aztiq
- TA Associates
Work highlights
- Advised CBC Group-funded Hasten (HK) Pharmaceuticals on the acquisition of a specialist pharmaceuticals portfolio from Korea’s Celltrion.
- Advised global private equity capital advisory firm M3 Capital Partners on the divestment of its global private equity capital advisory business to GLP Capital Partners.
- Advised CDH Investments, a China-focused alternative asset manager, on a number of significant transactions.
Practice head
The lawyer(s) leading their teams.
Hong Zhang, Dereck Poon